SAN DIEGO, June 7 /PRNewswire-FirstCall/ -- Metabasis Therapeutics
(Nasdaq: MBRX), announced today that Mr. John Beck, senior vice president
of finance and CFO of Metabasis will present at the Needham & Company, LLC
Fifth Annual Biotechnology and Medical Technology Conference at The Palace
Hotel in New York, NY. Mr. Beck is scheduled to present on Wednesday, June
14, 2006 at 8:30 a.m. Eastern Time, and is expected to provide an overview
of the Company's progress and discuss product candidates in clinical
development.
To access the live broadcast and the subsequent archived recording of
the presentation, please log onto the Company's website at http://www.mbasis.com
under the "Investors" section. The audio recording and presentation will be
archived there for 30 days following the live presentation. Please connect
to Metabasis' website several minutes prior to the start of the
presentation to ensure adequate time for any software download that may be
necessary.
About Metabasis (http://www.mbasis.com):
Metabasis Therapeutics is a biopharmaceutical company focused on the
discovery, development and commercialization of novel drugs to address some
of the world's most widespread and costly chronic diseases involving
pathways in the liver. The Company has established a pipeline that includes
clinical stage and preclinical product candidates targeting major diseases
with significant unmet medical needs. Targeted diseases include major
metabolic diseases such as diabetes, hyperlipidemia and obesity as well as
liver diseases such as hepatitis and primary liver cancer. Metabasis has
developed several proprietary technologies for use in discovering and
optimizing drugs, including the NuMimetic(TM) and HepDirect(R)
technologies. Metabasis is continuing to identify and develop new product
candidates using its proprietary technologies and expertise.
SOURCE Metabasis Therapeutics
 back to top
Related links:
http://www.mbasis.com
CONTACT:
Constance Bienfait, Vice President, Investor
Relations & Corporate Communications of Metabasis Therapeutics,
Inc., +1-858-622-5575
|
